Brian P Slingsby

Title: Brian P Slingsby: Innovator in Pyrimidinone Compounds

Introduction

Brian P Slingsby is a notable inventor based in St. Albans, GB. He has made significant contributions to the field of chemistry, particularly in the development of pyrimidinone compounds. His innovative work has led to the filing of a patent that showcases his expertise and creativity in this area.

Latest Patents

Brian P Slingsby holds a patent for a process for preparing substituted pyrimidinones. This invention provides a method for the preparation of pyrimidinone compounds with a group R²CH(OH) at the 5-position, where R² is an optionally substituted acid-stable 5- or 6-membered nitrogen-containing heteroaryl group. The pyrimidinone ring is further substituted by a side-chain of an H₁-antagonist or H₂-antagonist or a precursor thereof. The compounds developed through this process are convertible to 5-heteroaryl methyl compounds, which are useful as H₁- or H₂-antagonists or their precursors. This patent highlights his innovative approach to pharmaceutical chemistry.

Career Highlights

Brian P Slingsby is associated with Smith Kline & French Laboratories Limited, where he has contributed to various research projects. His work has focused on the synthesis and application of novel chemical compounds, particularly in the pharmaceutical industry. His dedication to research and development has positioned him as a valuable asset in his field.

Collaborations

Brian has collaborated with John Kitteringham, enhancing the research efforts at Smith Kline & French Laboratories Limited. Their combined expertise has led to advancements in the development of new chemical processes and compounds.

Conclusion

Brian P Slingsby is a distinguished inventor whose work in the preparation of substituted pyrimidinones has made a significant impact in the field of chemistry. His contributions continue to influence the development of pharmaceutical compounds, showcasing the importance of innovation in science.